At the news
? NEUTRALIMPACT 3/10 144 filed May 4, 2026 at 16:04 ET
Elizabeth Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 20,000 shares of common stock valued at approximately $900,000, acquired via stock option exercise. The sale is part of ongoing insider selling, but the amount relative to market cap is small and not material.
- Elizabeth Reed (officer) intends to sell 20,000 shares
- Estimated value of $900,000
- Shares acquired via stock option exercise
- Sale to be executed through Morgan Stanley
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access